Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study
- PMID: 16171867
- DOI: 10.1016/j.ophtha.2005.05.026
Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study
Abstract
Objective: To describe the incidence, prevalence, and natural history of proliferative sickle cell retinopathy (PSR).
Design: Prospective longitudinal study over 20 years.
Participants: Newborn screening of 100000 consecutive deliveries from 1973 to 1981 identified 315 children with homozygous sickle cell (SS) disease and 201 with SS-hemoglobin C (SC) disease. By the age of 5 years, 307 SS patients and 166 SC patients were alive and living in Jamaica and were recruited for this ophthalmic study.
Methods: Description of retinal vascular changes on annual angiography and angioscopy.
Main outcome measures: Incidence and prevalence of PSR and its behavior on follow-up. Progression of PSR was investigated using the number of eyes affected (none, one, both) and the interval until PSR onset.
Results: At last review in January 2000, PSR had developed in 59 patients (14 SS, 45 SC), unilaterally in 36 patients and bilaterally in 23. Incidence increased with age in both genotypes, with crude annual incidence rates of 0.5 cases (95% confidence interval [CI], 0.3-0.8) per 100 SS subjects and 2.5 cases (95% CI, 1.9-3.3) per 100 SC subjects. Prevalence was greater in SC disease, and by the ages of 24 to 26 years, PSR had occurred in 43% subjects with SC disease and in 14% subjects with SS disease. Patients with unilateral PSR had a 16% (11% SS, 17% SC) probability of regressing to no PSR and a 14% (16% SS, 13% SC) probability of progressing to bilateral PSR. Those with bilateral PSR had an 8% (8% SS, 8% SC) probability of regressing to unilateral PSR and a 1% (0 SS, 2% SC) probability of regressing to a PSR-free state. Irretrievable visual loss occurred in only 1 of 82 PSR-affected eyes, and 1 required detachment surgery and recovered normal visual acuity.
Conclusions: Longitudinal observations over 20 years in a cohort of patients followed from birth confirms a greater incidence and severity of PSR in SC disease, and shows that spontaneous regression occurred in 32% of PSR-affected eyes. Permanent visual loss was uncommon in subjects observed up to the age of 26 years.
Similar articles
-
Fecundity and pregnancy outcome in a cohort with sickle cell-haemoglobin C disease followed from birth.BJOG. 2005 Sep;112(9):1308-14. doi: 10.1111/j.1471-0528.2005.00678.x. BJOG. 2005. PMID: 16101613
-
Adolescent blood pressure in a cohort study of sickle cell disease.Arch Intern Med. 1993 May 24;153(10):1233-6. Arch Intern Med. 1993. PMID: 8494475
-
[Sickle cell disease and retinal damage: a study of 38 cases at the African Tropical Ophthalmology Institute (IOTA) in Bamako].Med Trop (Mars). 2006 Jun;66(3):252-4. Med Trop (Mars). 2006. PMID: 16924816 French.
-
Ophthalmologic complications in hemoglobinopathies.Hematol Oncol Clin North Am. 1991 Jun;5(3):535-48. Hematol Oncol Clin North Am. 1991. PMID: 1864821 Review.
-
Neurological complications of sickle cell anaemia at KNH: a five year retrospective study.East Afr Med J. 1992 Dec;69(12):660-2. East Afr Med J. 1992. PMID: 1298628 Review.
Cited by
-
The Impact of Optical Coherence Tomography in the Early Identification of Children with Sickle Cell Retinopathy.Int J Clin Pract. 2022 Aug 29;2022:9131423. doi: 10.1155/2022/9131423. eCollection 2022. Int J Clin Pract. 2022. PMID: 36105789 Free PMC article.
-
Relationship between paramacular thinning, cerebral vasculopathy, and hematological risk factors in sickle cell disease.Front Med (Lausanne). 2023 Aug 28;10:1226210. doi: 10.3389/fmed.2023.1226210. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37700770 Free PMC article.
-
Action on sickle cell retinopathy: the time is now.Eye (Lond). 2022 Jun;36(6):1138-1139. doi: 10.1038/s41433-021-01918-y. Epub 2022 Jan 28. Eye (Lond). 2022. PMID: 35087214 Free PMC article. No abstract available.
-
Sickle cell retinopathy in pediatric patients: exploring correlations and predictive factors.Graefes Arch Clin Exp Ophthalmol. 2025 Aug 23. doi: 10.1007/s00417-025-06946-y. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 40848190
-
How I treat the older adult with sickle cell disease.Blood. 2018 Oct 25;132(17):1750-1760. doi: 10.1182/blood-2018-03-818161. Epub 2018 Sep 11. Blood. 2018. PMID: 30206116 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical